Journal

PDRN Injection vs. PDRN Cream

One is a clinical treatment. The other is skincare. The difference isn't marketing — it's molecular. Here's what each actually does, and how to use both in a routine.

Updated April 2026
9 min read

PDRN has become one of the most hyped ingredients in Korean skincare over the past two years. Korean dermatologists have used injectable PDRN (under the brand name Rejuran) since 2014. Now it's appearing on the ingredient lists of creams, serums, and ampoules from dozens of K-beauty brands — from luxury clinical lines to drugstore ampoules.

This creates confusion. When someone sees "PDRN" on a $60 Korean cream at Olive Young and also hears about PDRN injections from a Gangnam dermatologist that cost $300 per session, they reasonably wonder: is this the same thing? Is the cream just a cheaper version? Does the cream work?

The answer is more nuanced than either "yes, it's the same" or "no, cream is useless." Both forms exist because they address different goals. Understanding the difference helps you spend money on the right version for what you actually want.

What PDRN Actually Is

PDRN stands for polydeoxyribonucleotides — fragments of DNA, typically derived from salmon sperm or trout roe, that have been purified and sterilized to pharmaceutical standards. The specific fragments used in Korean medical products range from 50 to 1,500 base pairs in length.

These DNA fragments don't encode any functional genetic information. They're too short and fragmented to affect your cells' genetic machinery. What they do is bind to adenosine A2A receptors on the surface of fibroblasts (the cells that produce collagen, elastin, and hyaluronic acid in your skin) and trigger a regenerative cellular response. The fragments also provide raw nucleotide building blocks that cells can use to support their own DNA repair processes.

The biological effect is cellular regeneration — increased fibroblast activity, improved cellular metabolism, enhanced DNA repair, and upregulation of the matrix proteins that keep skin firm, smooth, and hydrated. For more on the science of PDRN and the broader polynucleotide ingredient category, see our guide to PDRN and exosome therapy in Korea.

The key point for this comparison: the biological effect only happens when PDRN reaches fibroblasts in the dermis. This is the technical problem that separates injection from topical.

How Injection Delivers PDRN to Fibroblasts

Injectable PDRN, sold in Korea under brand names Rejuran Healer, Rejuran HB, Rejuran I, and Rejuran S, is delivered via microinjection directly into the dermis. The injection places the PDRN fragments at a depth of 0.5–1.5mm below the skin surface — exactly where fibroblasts live.

At this depth, the fragments are immediately available for uptake by fibroblasts. There's no delivery problem. The PDRN is where it needs to be the moment it's injected. The clinical effect is predictable, measurable, and dose-dependent.

A typical Rejuran Healer session delivers approximately 2cc of PDRN solution across 50–200 injection points on the face, containing a standardized concentration of roughly 20mg/mL of PDRN. The patient receives a clinical dose of active ingredient that has been tested in Korean clinical trials and refined over a decade of dermatology use.

For a complete walkthrough of the Rejuran injection procedure, what to expect during treatment, and how it's priced in Seoul versus the US, see our complete Rejuran Healer guide and cost comparison analysis.

Why Topical PDRN Is Harder

Topical PDRN has a fundamental delivery problem: the skin is designed to keep things out. Specifically, the stratum corneum — the outermost 10–30 micrometers of dead keratin-filled cells — is nearly impermeable to molecules above 500 daltons, and extremely selective about what passes through.

PDRN fragments are much larger than 500 daltons. A single nucleotide weighs roughly 330 daltons, and PDRN fragments contain anywhere from 50 to over 1,500 nucleotides linked together. A 100-base-pair PDRN fragment weighs roughly 33,000 daltons — about 65 times the threshold for easy skin penetration.

This means that most PDRN creams and serums have a real problem: the active ingredient is sitting on top of skin that can't absorb it. The PDRN might provide surface-level benefits (it's hydrating and has some antioxidant activity), but it cannot reach fibroblasts through standard topical application.

Korean brands have addressed this problem in three ways, with varying degrees of success.

How Topical PDRN Brands Solve the Penetration Problem

Strategy 1: Lower molecular weight fragments. Some brands use enzymatically fragmented PDRN that has been broken into smaller pieces (sometimes as short as 20–50 base pairs). These smaller fragments can penetrate partially through compromised skin or through follicle-mediated pathways. The tradeoff is that smaller fragments bind A2A receptors less effectively than the intact larger fragments used in injection. You get better penetration but lower per-molecule biological activity.

Strategy 2: Enhanced delivery systems. Brands like Rejuran's cosmetic line and VT Cosmetics use liposomal encapsulation, ethosomes, or solid lipid nanoparticles to improve PDRN penetration through the stratum corneum. These delivery vehicles can improve absorption by 3–10x compared to free PDRN. They're more effective than plain PDRN creams but still don't match injection efficacy.

Strategy 3: Physical disruption of the skin barrier. This is where the most interesting innovations have emerged. VT Cosmetics' Reedle Shot products contain "spicules" — microscopic silica-based crystals that create temporary microchannels through the stratum corneum when the product is massaged into skin. These channels allow PDRN to bypass the barrier and reach deeper layers. Other brands use microneedle patches that embed dissolving PDRN-loaded needles directly into the skin. Both approaches are meaningfully more effective than standard creams, though still less effective per application than injection.

For a deeper dive into ingredient delivery systems and penetration science, see our Korean skincare ingredient guide.

Realistic Effectiveness Comparison

Honest clinical comparison between injection and topical PDRN at their best formulations:

Injectable PDRN (Rejuran):

Topical PDRN (best-in-class formulations):

The honest summary: topical PDRN at its best delivers maybe 15–30% of the biological effect of injection, but does so daily over months instead of in single sessions. This makes it genuinely useful as maintenance or as an entry point, but inadequate as a primary treatment for significant clinical concerns.

When to Choose Each

Choose injection if you have:

Choose topical if you:

Consider combining both if you:

Notable Topical PDRN Products in Korean Skincare

A non-exhaustive list of topical PDRN products that have clinical credibility in Korea, organized by delivery approach:

Spicule delivery (highest efficacy for topical):

Clinical formulations from Rejuran brand family:

Concentrated ampoules:

Entry-level options:

Be aware that "PDRN" appearing on an ingredient list doesn't guarantee meaningful concentration. Brands are not required to disclose percentage, and many products include trace amounts of PDRN primarily for marketing purposes. Look for brands that publish concentration data or clinical testing, or that use spicule/microneedle delivery systems that only make sense if there's enough PDRN to deliver.

Cost Per Use Comparison

Putting real numbers to the cost question:

Injectable PDRN (Rejuran Healer in Seoul):

Topical PDRN (premium Korean brands):

The total annual cost is actually comparable, but the experience is completely different. Injection front-loads the cost and provides concentrated results. Topical spreads cost evenly and provides maintenance-level benefits daily. Neither is categorically "cheaper" — they're different products purchased for different reasons.

A Practical Recommendation

If you can travel to Seoul once every 12–18 months, the optimal protocol is usually: get a course of Rejuran Healer injections during your Seoul trip (3 sessions over 8 weeks), then maintain results with a high-quality topical PDRN product daily between trips. This combines the clinical efficacy of injection with the daily maintenance benefits of topical application.

If you cannot travel to Seoul, a clinical-grade topical PDRN routine using spicule or microneedle delivery products can still produce meaningful results over 6–12 months of consistent use. It won't match injection, but it's not nothing.

If you're building a Korean-style clinical routine from scratch, see our complete glass skin routine guide for how PDRN fits into a structured routine alongside peptides, ceramides, and barrier repair ingredients. For context on which treatments are worth traveling to Seoul for, see our Seoul skincare tourism guide.

Frequently Asked Questions

Does PDRN cream work?
Yes, but with caveats. Topical PDRN delivers real benefits for hydration, barrier support, and surface smoothness, and with advanced delivery systems (spicules, microneedles), it can provide meaningful fibroblast activation. It does not match the clinical effect of injection for texture, scarring, or deep cellular regeneration.

Is PDRN cream safe?
Topical PDRN is considered safe for most skin types. PDRN itself is an inert biological molecule with an excellent safety profile. The concerns with topical PDRN are typically related to other ingredients in the formulation (fragrances, preservatives) rather than PDRN itself.

Can I use PDRN cream with retinol?
Yes, and this is often an effective pairing. PDRN supports barrier recovery from retinol use. Most routines use PDRN in the morning and retinol at night, or PDRN immediately after retinol to soothe the skin. See our glass skin routine guide for how to sequence actives.

Where can I buy clinical-grade topical PDRN products?
In Korea, Olive Young carries most consumer PDRN lines. For clinical-grade products, dermatology clinics in Gangnam often dispense private-label PDRN ampoules. Outside Korea, availability is limited and pricing is marked up significantly. We're launching clinical-grade Korean skincare in 2026 — join the list here.

Clinical Korean skincare, coming to the US. We're bringing Seoul's clinical-grade PDRN serums, peptide treatments, and barrier repair creams to American consumers. Founding members get early access and launch pricing. Get on the list →